Spectrum of Neurocutaneous Syndromes in Children in Neurology Practice

Abstract

Neurocutaneous syndromes (NCSs) are a well-recognized cause of neurological dysfunction in children. While there is large body of literature describing individual neurocutaneous disorders, composite studies describing the relative frequency of these disorders and their modes of presentation in pediatric neurology practice are sparse. Charts of 87 children, 54 boys and 33 girls, with NCSs were reviewed. Tuberous sclerosis was diagnosed in 47 children, followed by neurofibromatosis type 1 and ataxia-telangiectasia in 10 each. Six children had Sturge-Weber syndrome, five had hypomelanosis of Ito, and three had Sjogren-Larsson syndrome. Sixty children presented with seizures, of which 46 had tuberous sclerosis. Others presented with developmental delay and ataxia/movement disorder. Family history of NCS was noted in 20 (21.6%) children. Thirty-four (39%) children had developmental delay or intellectual disability at the time of presentation. Our study reveals that tuberous sclerosis is the most common NCS in pediatric neurology practice.

Keywords

neurocutaneous - children - neurofibromatosis - tuberous sclerosis - epilepsy

Authors' Contributions

J.S.G. conceptualized the study, reviewed the literature, and wrote the initial draft. S.K. (Sukhjot Kaur) reviewed the relevant dermatological literature and critically revised the manuscript. S.K. (Simrat Kaur) compiled and analyzed the data and also reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

• References

• 1 Roach ES. Diagnosis and management of neurocutaneous syndromes. Semin Neurol 1988; 8 (01) 83-96
• 2 Little H, Kamat D, Sivaswamy L. Common neurocutaneous syndromes. Pediatr Ann 2015; 44 (11) 496-504
• 3 Flores-Sarnat L, Sarnat HB. Embryology of neurocutaneous syndromes. In: Ruggieri M, Pascual-Castroviejo I, Rocco CD. , eds., Neurocutaneous Disorders: Phakomatoses and Hamartoneoplastic Syndromes. New York: Springer Wien; 2008: 1-17
• 4 Roach ES, Miller VS. Introduction. In: Roach ES, Miller VS. , eds. Neurocutaneous Disorders. Cambridge: Cambridge University Press; 2004: 1-5
• 5 Purkait R, Samanta T, Thakur S, Dhar S. Neurocutaneous syndrome: a prospective study. Indian J Dermatol 2011; 56 (04) 375-379
• 6 National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1988; 1 (03) 172-178
• 7 Hersh JH. ; American Academy of Pediatrics Committee on Genetics. Health supervision for children with neurofibromatosis. Pediatrics 2008; 121 (03) 633-642
• 8 Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123 (01) 124-133
• 9 Vivarelli R, Grosso S, Calabrese F. , et al. Epilepsy in neurofibromatosis 1. J Child Neurol 2003; 18 (05) 338-342
• 10 Ostendorf AP, Gutmann DH, Weisenberg JLZ. Epilepsy in individuals with neurofibromatosis type 1. Epilepsia 2013; 54 (10) 1810-1814
• 11 Northrup H, Krueger DA. ; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49 (04) 243-254
• 12 Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet 2008; 372 (9639): 657-668
• 13 van Os NJH, Haaxma CA, van der Flier M. , et al; A-T Study Group. Ataxia-telangiectasia: recommendations for multidisciplinary treatment. Dev Med Child Neurol 2017; 59 (07) 680-689
• 14 Bachur CD, Comi AM. Sturge-weber syndrome. Curr Treat Options Neurol 2013; 15 (05) 607-617
• 15 Shirley MD, Tang H, Gallione CJ. , et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368 (21) 1971-1979
• 16 Pascual-Castroviejo I, Roche C, Martinez-Bermejo A. , et al. Hypomelanosis of ITO. A study of 76 infantile cases. Brain Dev 1998; 20 (01) 36-43
• 17 Cory RC, Clayman DA, Faillace WJ, McKee SW, Gama CH. Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). AJNR Am J Neuroradiol 1997; 18 (04) 751-757
• 18 Stone J. Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 2003; 61 (05) 674-676
• 19 Willemsen MA, IJlst L, Steijlen PM. , et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 2001; 124 (Pt 7): 1426-1437
• 20 Gordon N. Sjögren-Larsson syndrome. Dev Med Child Neurol 2007; 49 (02) 152-154
• 21 Fuijkschot J, Theelen T, Seyger MM. , et al. Sjögren-Larsson syndrome in clinical practice. J Inherit Metab Dis 2012; 35 (06) 955-962
• 22 Lyon VB. Congenital melanocytic nevi. Pediatr Clin North Am 2010; 57 (05) 1155-1176
• 23 Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993; 30 (01) 53-59
• 24 Sugarman JL. Epidermal nevus syndromes. Semin Cutan Med Surg 2007; 26 (04) 221-230
• 25 Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011; 19 (06) 617-623